Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Gisslén

Showing results (1-10 of 229) with videos related to

Pageof 23
Sort By:
AIDS Research and Therapy|February 24, 2007
Retroviral rebound syndrome after treatment discontinuation in a 15 year old girl with HIV attracted through mother-to-child transmission: case reportVanda Friman, Magnus Gisslén
BMJ Open|May 17, 2023
Cohort profile: a longitudinal study of HIV infection in the central nervous system with focus on cerebrospinal fluid - the Gothenburg HIV CSF Study CohortLars Hagberg, Magnus Gisslén
Lakartidningen|October 30, 2024
Anders Ternhag, Magnus Gisslén
Lakartidningen|November 27, 2002
[Swedish guidelines for antiretroviral treatment of HIV. Good compliance is crucial for a good result]Magnus Gisslén, Anders Sönnerborg
Therapeutics and Clinical Risk Management|April 2, 2009
Once-daily fosamprenavir with ritonavir in the treatment of HIV infection in therapy-naïve patientsLeo Flamholc, Magnus Gisslén
Seminars in Neurology|April 10, 2014
Treatment of HIV in the Central Nervous SystemAylin Yilmaz, Magnus Gisslén
Lakartidningen|September 30, 2022
Helena Hervius Askling, Magnus Gisslén
The Journal of Infectious Diseases|January 23, 2019
Antiretroviral Treatment of Acute HIV Infection Normalizes Levels of Cerebrospinal Fluid Markers of Central Nervous System (CNS) Inflammation: A Consequence of a Reduced CNS Reservoir?Magnus Gisslén, Peter W Hunt
Lakartidningen|January 12, 2023
Fredrik Kahn, Fredrik Månsson, Magnus Gisslén
Expert Review of Molecular Diagnostics|May 20, 2025
Neurofilament light chain as a biomarker for neuronal injury in CNS infectionsLars Hagberg, Henrik Zetterberg, Magnus Gisslén
Pageof 23

Showing results (1-10 of 229) with videos related to

Sort By:
Pageof 23
AIDS Research and Therapy|February 24, 2007
Retroviral rebound syndrome after treatment discontinuation in a 15 year old girl with HIV attracted through mother-to-child transmission: case reportVanda Friman, Magnus Gisslén
BMJ Open|May 17, 2023
Cohort profile: a longitudinal study of HIV infection in the central nervous system with focus on cerebrospinal fluid - the Gothenburg HIV CSF Study CohortLars Hagberg, Magnus Gisslén
Lakartidningen|October 30, 2024
Anders Ternhag, Magnus Gisslén
Lakartidningen|November 27, 2002
[Swedish guidelines for antiretroviral treatment of HIV. Good compliance is crucial for a good result]Magnus Gisslén, Anders Sönnerborg
Therapeutics and Clinical Risk Management|April 2, 2009
Once-daily fosamprenavir with ritonavir in the treatment of HIV infection in therapy-naïve patientsLeo Flamholc, Magnus Gisslén
Seminars in Neurology|April 10, 2014
Treatment of HIV in the Central Nervous SystemAylin Yilmaz, Magnus Gisslén
Lakartidningen|September 30, 2022
Helena Hervius Askling, Magnus Gisslén
The Journal of Infectious Diseases|January 23, 2019
Antiretroviral Treatment of Acute HIV Infection Normalizes Levels of Cerebrospinal Fluid Markers of Central Nervous System (CNS) Inflammation: A Consequence of a Reduced CNS Reservoir?Magnus Gisslén, Peter W Hunt
Lakartidningen|January 12, 2023
Fredrik Kahn, Fredrik Månsson, Magnus Gisslén
Expert Review of Molecular Diagnostics|May 20, 2025
Neurofilament light chain as a biomarker for neuronal injury in CNS infectionsLars Hagberg, Henrik Zetterberg, Magnus Gisslén
Pageof 23